Nanomedicine - Real-time screening of the size of nanoparticles during production
Can't see this email? View it online
   
  Nanomedicine  
  The latest nanomedicine news from News Medical  
 

Bioactivity Testing for Medical Implants Bioactivity Testing for Medical Implants

Bioactivity testing is an essential part of ensuring both the safety and efficacy of bioactive medical implants. In the case of bioactive glass, bioactivity testing is used to ensure the efficacy of different bioactive glasses in promoting bone regeneration.

Discover More
 
 
    Real-time screening of the size of nanoparticles during production Real-time screening of the size of nanoparticles during production
 
Particle size is a critical attribute in drug delivery applications. Real-time multi-angle light scattering ensures batch consistency by in-line monitoring the size of particles during production and eliminating outliers.
 
Find out more
 
 
   What is the role of a niclosamide-based organic/inorganic hybrid in the suppression of SARS-CoV-2 infections?What is the role of a niclosamide-based organic/inorganic hybrid in the suppression of SARS-CoV-2 infections?
 
A new study involved the preparation of NIC-MgO and NIC-MgO-HPMC by solid-state intercalation reaction followed by cetrimonium bromide (CTAB) stabilized NIC-MgO and MgO Nanoparticles (NP) preparation.
 
 Study may help overcome some obstacles to the development of nanoparticle-based drugs
 
Study may help overcome some obstacles to the development of nanoparticle-based drugsUsing nanoparticles to deliver cancer drugs offers a way to hit tumors with large doses of drugs while avoiding the harmful side effects that often come with chemotherapy.
 
 
 Charged nanoparticles combined with a vaccine effective in eliminating melanoma tumors in mice
 
Charged nanoparticles combined with a vaccine effective in eliminating melanoma tumors in miceCancers in humans have all sorts of ways to survive and thrive: Cells and tumors alike engage in devious means to deflect, deceive, and evade detection by our bodies’ immune systems.
 
 
 Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients
 
Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patientsA multicenter, randomized, placebo-controlled phase 2a clinical trial has recently been conducted to evaluate the efficacy of a nanotherapeutic compound OP-101 in treating severe COVID-19 patients.
 
 
 Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responses
 
Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responsesSmall proteins, called chemokines, that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study by researchers at Weill Cornell Medicine and Hospital for Special Surgery (HSS).
 
 
 Researchers develop new SERS method for active capture of target molecules
 
Researchers develop new SERS method for active capture of target moleculesRecently, a team led by Prof. Yang Liangbao from Hefei Institutes of Physical Science, Chinese Academy of Sciences used the nano-capillary pumping action to automatically capture the target molecules into a smaller gap and achieve highly sensitive Surface-Enhanced Raman Spectroscopy (SERS) detection by constructing a multilayer nanoparticle film to form a natural gap of less than 3 nm between the layers.